RSH Stock Overview
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
Respiri Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | AU$0.033 |
| 52 Week High | AU$0.053 |
| 52 Week Low | AU$0.021 |
| Beta | -0.027 |
| 1 Month Change | 10.00% |
| 3 Month Change | 43.48% |
| 1 Year Change | -29.79% |
| 3 Year Change | -73.60% |
| 5 Year Change | -64.89% |
| Change since IPO | -97.16% |
Recent News & Updates
Recent updates
Respiri Limited's (ASX:RSH) CEO Will Probably Find It Hard To See A Huge Raise This Year
Nov 08
We're Keeping An Eye On Respiri's (ASX:RSH) Cash Burn Rate
Aug 17Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation
Apr 29Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation
Jan 03Here's Why We're Watching Respiri's (ASX:RSH) Cash Burn Situation
Sep 21We Think Respiri (ASX:RSH) Can Afford To Drive Business Growth
Jun 07Respiri (ASX:RSH) Is In A Good Position To Deliver On Growth Plans
Feb 22Shareholder Returns
| RSH | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 0% | 2.1% | 0.9% |
| 1Y | -29.8% | 13.8% | 5.6% |
Return vs Industry: RSH underperformed the Australian Medical Equipment industry which returned 13.8% over the past year.
Return vs Market: RSH underperformed the Australian Market which returned 5.6% over the past year.
Price Volatility
| RSH volatility | |
|---|---|
| RSH Average Weekly Movement | 16.0% |
| Medical Equipment Industry Average Movement | 10.5% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in AU Market | 17.6% |
| 10% least volatile stocks in AU Market | 3.5% |
Stable Share Price: RSH's share price has been volatile over the past 3 months.
Volatility Over Time: RSH's weekly volatility (16%) has been stable over the past year, but is still higher than 75% of Australian stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Marjan Mikel | respiri.co |
Respiri Limited, an e-health SaaS company, researches, develops, and commercializes medical devices in Australia. The company develops, produces, and sells mobile health applications. Its products include wheezo, an electronic wheeze detection tool to detect wheeze in children; respiri mobile application; and Respiri health portal.
Respiri Limited Fundamentals Summary
| RSH fundamental statistics | |
|---|---|
| Market cap | AU$34.98m |
| Earnings (TTM) | -AU$6.39m |
| Revenue (TTM) | AU$789.74k |
44.3x
P/S Ratio-5.5x
P/E RatioIs RSH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RSH income statement (TTM) | |
|---|---|
| Revenue | AU$789.74k |
| Cost of Revenue | AU$23.74k |
| Gross Profit | AU$766.00k |
| Other Expenses | AU$7.15m |
| Earnings | -AU$6.39m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.006 |
| Gross Margin | 96.99% |
| Net Profit Margin | -808.52% |
| Debt/Equity Ratio | 0% |
How did RSH perform over the long term?
See historical performance and comparison